DRKS00005807招募中不适用
Refractory Rheumatoid Arthritis - The reRA Study
Abteilung für RheumatologieMedizinische Universität Wien0 个研究点目标入组 219 人开始时间: 2014年2月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 219
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Rheumatoide arthritis:
- •Cases (refractory RA): high/ moderate disease activity despite >4 DMARDs; Controls: achievement of remission/low disease activity within th first two DMARD courses.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014881agasaki University Hospital250
招募中
不适用
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, through application of musculoskeletal ultrasonography and treatment for periodontal disease, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014886agasaki University Hospital250
进行中（未招募）
1 期
REDO study: Research into the effects of lower doses rituximab in patients with rheumatoid arthritisRheumatoid arthritisEUCTR2016-002908-15-NLSint Maartenskliniek140
已完成
不适用
Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR StudyRheumatoid ArthritisJPRN-UMIN000007539niversity of Occupational and Environmental Health, Japan108
暂停
不适用
The RAINBOW study: Rheumatoid Arthritis ImplemeNtation of Biological dose Optimization in real WorldRheumatoid Arthritis (RA)NL-OMON22185This is an investigator-initiated study, funded by the Sint Maartenskliniek320